BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25701806)

  • 1. Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers.
    Frenz T; Grabski E; Durán V; Hozsa C; Stępczyńska A; Furch M; Gieseler RK; Kalinke U
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):13-7. PubMed ID: 25701806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
    Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
    J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations.
    Joshi MD; Unger WW; van Beelen AJ; Bruijns SC; Litjens M; van Bloois L; Kalay H; van Kooyk Y; Storm G
    Int J Pharm; 2011 Sep; 416(2):426-32. PubMed ID: 21371544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-type lectin receptor SIGNR1 expressed on peritoneal phagocytic cells with an immature dendritic cell-like phenotype is involved in uptake of oligomannose-coated liposomes and subsequent cell maturation.
    Kawauchi Y; Igarashi M; Kojima N
    Cell Immunol; 2014 Feb; 287(2):121-8. PubMed ID: 24491912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses.
    Boks MA; Ambrosini M; Bruijns SC; Kalay H; van Bloois L; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Oct; 216():37-46. PubMed ID: 26151293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
    Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting C-type lectin receptors with multivalent carbohydrate ligands.
    Lepenies B; Lee J; Sonkaria S
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1271-81. PubMed ID: 23727341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite regulatory effects of IFN-β and IL-3 on C-type lectin receptors, antigen uptake, and phagocytosis in human macrophages.
    Cardone M; Ikeda KN; Varano B; Belardelli F; Millefiorini E; Gessani S; Conti L
    J Leukoc Biol; 2014 Jan; 95(1):161-8. PubMed ID: 24018352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo targeting of DC-SIGN-positive antigen-presenting cells in a nonhuman primate model.
    Pereira CF; Torensma R; Hebeda K; Kretz-Rommel A; Faas SJ; Figdor CG; Adema GJ
    J Immunother; 2007 Oct; 30(7):705-14. PubMed ID: 17893563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FcγRIIa cross-talk with TLRs, IL-1R, and IFNγR selectively modulates cytokine production in human myeloid cells.
    Vogelpoel LT; Hansen IS; Visser MW; Nagelkerke SQ; Kuijpers TW; Kapsenberg ML; de Jong EC; den Dunnen J
    Immunobiology; 2015 Feb; 220(2):193-9. PubMed ID: 25108563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
    de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
    Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.
    Cruz LJ; Tacken PJ; Fokkink R; Joosten B; Stuart MC; Albericio F; Torensma R; Figdor CG
    J Control Release; 2010 Jun; 144(2):118-26. PubMed ID: 20156497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205.
    Badiee A; Davies N; McDonald K; Radford K; Michiue H; Hart D; Kato M
    Vaccine; 2007 Jun; 25(25):4757-66. PubMed ID: 17512099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells.
    Cambi A; Gijzen K; de Vries lJ; Torensma R; Joosten B; Adema GJ; Netea MG; Kullberg BJ; Romani L; Figdor CG
    Eur J Immunol; 2003 Feb; 33(2):532-8. PubMed ID: 12645952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells.
    Aarnoudse CA; Bax M; Sánchez-Hernández M; García-Vallejo JJ; van Kooyk Y
    Int J Cancer; 2008 Feb; 122(4):839-46. PubMed ID: 17957800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific uptake mechanisms of well-tolerated thermoresponsive polyglycerol-based nanogels in antigen-presenting cells of the skin.
    Edlich A; Gerecke C; Giulbudagian M; Neumann F; Hedtrich S; Schäfer-Korting M; Ma N; Calderon M; Kleuser B
    Eur J Pharm Biopharm; 2017 Jul; 116():155-163. PubMed ID: 28027923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses.
    Faisal SM; Chen JW; McDonough SP; Chang CF; Teng CH; Chang YF
    Vaccine; 2011 Mar; 29(13):2381-91. PubMed ID: 21300103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs.
    Francian A; Mann K; Kullberg M
    Int J Nanomedicine; 2017; 12():5149-5161. PubMed ID: 28790822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.